Cargando…

Safety and efficacy of toripalimab in advanced gastric cancer: A new clinical trial bringing hope for immunotherapy in gastric cancer

Detalles Bibliográficos
Autor principal:	Qiu, Haibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170659/ https://www.ncbi.nlm.nih.gov/pubmed/32277740 http://dx.doi.org/10.1002/cac2.12019

Ejemplares similares

High hopes and high honours for cancer immunotherapy
por: Häfner, Sophia Julia
Publicado: (2019)

CD5: from antiquated T cell marker to immunotherapy’s new hope
por: Schwarz, Sandra, et al.
Publicado: (2023)

Complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: results of a propensity score matching analysis from France
por: Qiu, Haibo
Publicado: (2019)

Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)

Toripalimab in advanced biliary tract cancer
por: Li, Wei, et al.
Publicado: (2022)

Efficacy and Safety of Regorafenib Combined with Toripalimab in the Third-Line and beyond Treatment of Advanced Colorectal Cancer
por: Yu, Wei, et al.
Publicado: (2021)

Anlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma
por: Jiang, Man, et al.
Publicado: (2022)

Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer
por: Folprecht, Gunnar
Publicado: (2019)

Combined immunotherapy for advanced prostate cancer: Empowering the T cell army
por: Suleman, Sufyan, et al.
Publicado: (2017)

Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

New strategies for cancer immunotherapy: targeting regulatory T cells
por: Finotello, Francesca, et al.
Publicado: (2017)

Interactome analysis brings splicing into focus
por: Dominguez, Daniel, et al.
Publicado: (2015)

One patient, two lesions, two oncogenic drivers of gastric cancer
por: Alsinet, Clara, et al.
Publicado: (2014)

Multi-cancer blood testing combined with PET-CT: road for hope to screen for cancer and guide intervention
por: Jiang, Tao, et al.
Publicado: (2020)

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021)

Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC
por: Wang, Yunchao, et al.
Publicado: (2023)

Constant regulation for stable CD8 T‐cell functional avidity and its possible implications for cancer immunotherapy
por: Gilfillan, Connie B., et al.
Publicado: (2021)

What will membrane vesicles (MVs) bring to bacterial communication?
por: Toyofuku, Masanori, et al.
Publicado: (2017)

New strategy for cancer immunotherapy: using live engineered bacteria for metabolic modulation
por: Li, Tong, et al.
Publicado: (2021)

S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer
por: Diao, Feiyu, et al.
Publicado: (2019)

Targeting multiple epitopes on the spike protein: a new hope for COVID-19 antibody therapy
por: Sun, Yeping, et al.
Publicado: (2020)

PARP inhibitors in gastric cancer: beacon of hope
por: Wang, Yali, et al.
Publicado: (2021)

Ipilimumab and Cancer Immunotherapy: A New Hope for Advanced Stage Melanoma
por: Mansh, Matthew
Publicado: (2011)

The New Era of Immunotherapy in Gastric Cancer
por: Takei, Shogo, et al.
Publicado: (2022)

Targeted therapies for gastric cancer: failures and hopes from clinical trials
por: Apicella, Maria, et al.
Publicado: (2017)

Probiotics Bring New Hope for Atherosclerosis Prevention and Treatment
por: Zhai, Taiyu, et al.
Publicado: (2022)

The pea aphid genome sequence brings theories of insect defense into question
por: Elsik, Christine G
Publicado: (2010)

Tumor‐derived microparticles in tumor immunology and immunotherapy
por: Ma, Jingwei, et al.
Publicado: (2020)

Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
por: Shen, Lin
Publicado: (2018)

MiR-596 down regulates SOX4 expression and is a potential novel biomarker for gastric cancer
por: Chen, Yongyi, et al.
Publicado: (2020)

A ‘fit’ microbiota to potentiate cancer immunotherapy
por: Rescigno, Maria
Publicado: (2015)

Normalization cancer immunotherapy: blocking Siglec-15!
por: Cao, Guangchao, et al.
Publicado: (2019)

Methionine restriction sensitizes cancer cells to immunotherapy
por: Lu, Weiqin, et al.
Publicado: (2023)

Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer
por: Liu, Guiyuan, et al.
Publicado: (2022)

Immunotherapy: A New Hope for Cancer Patients
por: Gupta, Shalini, et al.
Publicado: (2020)

The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer
por: He, Shenghui
Publicado: (2020)

Mesenchymal Stem Cells in Gastric Cancer: Vicious but Hopeful
por: Li, Yuyi, et al.
Publicado: (2021)

Immunotherapy in Gastric Cancer
por: Högner, Anica, et al.
Publicado: (2022)

Epigenetic checkpoint blockade: new booster for immunotherapy
por: Wang, Ziqiao, et al.
Publicado: (2021)

Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
por: Wang, F, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kn8r57tag9fmglta9lnligve0g